According to the South China Morning Post, U.S. healthcare venture capital firm RA Capital has established a new office in Shanghai to seek biopharmaceutical investment opportunities in China. Partner Josh Resnick stated that the firm currently has 12 employees in China, including four investment professionals who began working locally over the past few months. The available materials did not disclose the financial figures for any new investment transactions.